Literature DB >> 6657915

Prognostic factors predicting the outcome of sarcoidosis: an analysis of 818 patients.

E Neville, A N Walker, D G James.   

Abstract

A computerised, retrospective study of 818 patients with sarcoidosis was analysed to study the prognosis of each individual manifestation of the disease. The good prognosis of erythema nodosum, acute arthritis and bilateral hilar lymphadenopathy was confirmed, though 16 per cent of patients presenting with erythema nodosum pursued a chronic course. Cor pulmonale and nephrocalcinosis reflected the poorest prognosis while lupus pernio and sarcoidosis of the mucosa of the upper respiratory tract rarely resolved. Bone sarcoidosis also implied chronicity but in four of 31 patients there was no clinical evidence of disease activity two years after the initial diagnosis, although naturally the bone radiograph was still abnormal. Hepatomegaly carried a worse prognosis than splenomegaly, or indeed, than the finding of pulmonary mottling without hilar glands--a stage three chest radiograph.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6657915

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  47 in total

Review 1.  A clinical approach to the use of methotrexate for sarcoidosis.

Authors:  R P Baughman; E E Lower
Journal:  Thorax       Date:  1999-08       Impact factor: 9.139

2.  Intracellular cytokine repertoire in different T cell subsets from patients with sarcoidosis.

Authors:  M Möllers; S P Aries; D Drömann; B Mascher; J Braun; K Dalhoff
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

3.  Predictive value of gallium scan, angiotensin-converting enzyme level, and bronchoalveolar lavage in two-year follow-up of pulmonary sarcoidosis.

Authors:  R P Baughman; R Shipley; C E Eisentrout
Journal:  Lung       Date:  1987       Impact factor: 2.584

4.  Sarcoidosis as a risk factor for venous thromboembolism.

Authors:  Anna Goljan Geremek; Witold Tomkowski; Marcin Geremek; Elżbieta Puścińska; Grzegorz Małek; Adam Nowiński; Michal Bednarek; Paweł Śliwiński
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

5.  Early prediction of sarcoidosis prognosis with HLA typing: a 5 year follow-up study.

Authors:  Ezgi Ozyilmaz; Ozlem Goruroglu Ozturk; Ali Durmaz; Orhan Othman Hasan; Bugra Guzelbaba; Gulsah Seydaoglu; Sedat Kuleci; Ismail Hanta; Eren Erken; Ali Kocabas
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2018-04-28       Impact factor: 0.670

Review 6.  Sarcoidosis.

Authors:  D G Peckham; M A Spiteri
Journal:  Postgrad Med J       Date:  1996-04       Impact factor: 2.401

Review 7.  Sarcoidosis: the clinical problem.

Authors:  E Neville
Journal:  Postgrad Med J       Date:  1988-07       Impact factor: 2.401

8.  Increased risk of pulmonary embolism among US decedents with sarcoidosis from 1988 to 2007.

Authors:  Jeffrey J Swigris; Amy L Olson; Tristan J Huie; Evans R Fernandez-Perez; Joshua J Solomon; David Sprunger; Kevin K Brown
Journal:  Chest       Date:  2011-05-12       Impact factor: 9.410

Review 9.  Atypical Cutaneous Presentations of Sarcoidosis: Two Case Reports and Review of the Literature.

Authors:  David L Leverenz; Christopher Henderson; Ankoor Shah
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-14       Impact factor: 4.806

Review 10.  Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches.

Authors:  Nancy Casanova; Tong Zhou; Kenneth S Knox; Joe G N Garcia
Journal:  Clin Chest Med       Date:  2015-09-26       Impact factor: 2.878

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.